pavmed.com (PAVM) - יתרות מזומנים למניה אחת

PAVmed Inc. delegates sensor manufacturing to external contractors, focusing on patents and R&D. Cash per share demonstrates the company's liquidity, where the 1.09 level captures the current state of capital. This supports a staff of high-end engineers developing complex medical systems within an environment of creative freedom. Stable utilization of contract lines is complemented by regular updates to quality control equipment.
פילוחים אנליטיים של חברת PAVmed Inc.

PAVmed Inc. is developing a medtech incubator, focusing on the commercial implementation of EsoGuard diagnostic systems. The average cash per share reflects the volume of liquid reserves attributable to a single security. This metric measures financial autonomy, determining the company's ability to fund R&D without external borrowing. It is critical for investors to assess this reserve as a business survival buffer. This indicator confirms capital stability until monetization goals are achieved.